| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SYNTA PHARMACEUTICALS CORP | 30,194,898 | 90,887,000 | 93.55% | ||
| 2 | CELATOR PHARMACEUTICALS INC | 2,246,469 | 5,684,000 | 5.85% | ||
| 3 | COVIDIEN PLC | 4,381 | 379,000 | 0.39% | ||
| 4 | AGILE THERAPEUTICS, INC. | 27,415 | 200,000 | 0.21% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-14-006428, filed 2014.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
